We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
06/2/2018 22:20 | I see this fall as a gift from the stockmarket gods. Topped up. | montyhedge | |
06/2/2018 21:15 | GSK was $35.1 at the close of the LSE, it closed at $36 in the US. Might be a reasonable day for results as it should be a rebound day for the markets in general. | polaris | |
06/2/2018 21:12 | Dow closed up 2.3% GSK and Reckitt in final 2 to bid for consumer goods division So a two way pull tomorrow - Opening movements will be interesting - Looks as though down after hours in New York but who can tell, | pugugly | |
06/2/2018 21:12 | Dow up 567 points at close. | woodhawk | |
06/2/2018 20:06 | All being well tomorrow great bounce coming. Down from 1700p to 1242p.Crazy price with a 6.4% yield. | montyhedge | |
06/2/2018 18:19 | Hello hosede, Yes of course you are right.My cynicism relates to the plethora of pundits who seem to think that they know and can predict market direction.Whether broking houses or bulletin board experts.It is worth looking back at their predictions to see what a pointless exercise it has been. Fwiw the only ones with a modicum of success are those that look at the current trend and extrapolate on that.... works well in the very short term of course!GSK will go down before it retraces I think? | bili1946 | |
06/2/2018 17:23 | Usually a dip pre-release on GSK results day. And they've been later in the day with the release than usual the last two times if I recall correctly. A buying opportunity perhaps so long as Emma doesn't start talking about acquisitions and dividends again in the afternoon investor call. Not we can take another beating like that at this stage. | romeike | |
06/2/2018 15:55 | Posted yesterday on RKH thread buywell35 Feb '18 - 16:57 - 40508 of 40518 Edit OIL dropping General Market sell off now underway Watch the USA markets now drop another 2% today after ours closes RKH 20p retest cometh chartwise | buywell3 | |
06/2/2018 15:47 | I reckon over 1300p boys on the figures tomorrow. | montyhedge | |
06/2/2018 15:45 | It's called volatility Bili - we haven't seen much of it in the last 8 or 9 years | hosede | |
06/2/2018 15:06 | Dow forecast to be down 5/600pts a few minutes before opening .............30 mins after up 250.Tells you all you need to know about investing. | bili1946 | |
06/2/2018 14:42 | Hopefully 23p div and half decent figures, should be over 1300p tomorrow. | montyhedge | |
06/2/2018 14:17 | Pfizer comment this week suggests they are preparing the ground for no sale. The sooner GSK no deal is announced the better for all concerned. GSK results risk being overshadowed by global events as it is. | romeike | |
06/2/2018 13:03 | I think the sale will not bear fruit for either buyer so it's a NO,NO ! | abdullla | |
06/2/2018 12:45 | So GSK buys Pfizer's CP division. Pays over the odds Cuts div Share price plummets Vulture fund buys the whole shebang and then splits it into two separate companies and sells the pharma to Pfizer and the Consumer products to RB I think I should sell my smallholding! | toffeeman | |
06/2/2018 12:45 | GSK is an approx. £100bn company currently valued at £60bn by its share price On what planet do you value it at just £5bn? - come on get real. | romeike | |
06/2/2018 12:28 | Hopefully this hit to the market will focus minds at GSK re: price of any bid. Anything that isn't a bargain bid will be unacceptable when the focus is supposed to be on pharma. Confident that the current share price would itself be a bargain either way anyway - offers a crazy yield and good growth potential on a company with one of the best dividend histories on the London market. Wouldn't be surprised to see the Dow back to Trump election night levels, it's been a long time coming. The president might want to think twice before blowing huge stock market bubbles. No doubt this drop is all the democrats' fault, or possibly the FBI's fault or those horrible liberals who want distasteful things like basic equality. | romeike | |
06/2/2018 12:20 | Dow to retreat to its status quo position,TRUMP to join the jumpers ! | abdullla | |
06/2/2018 11:58 | Dow is on its way to under 20k in the coming days/weeks and gsk to 1k imo. | sr2day | |
06/2/2018 11:52 | After the DCBounce Dow looks to go down another 1000 points,imo ! | abdullla | |
06/2/2018 10:23 | Don't offer CASH ? pay in paper! | abdullla | |
06/2/2018 09:56 | If it spends anywhere near $15 Bln in the present competitive and consumer climate on Pfizer's consumer division the share price will hit £8. imo | cumnor | |
06/2/2018 09:52 | The CFO of Reckitt is ex GSK fwiw. | alphorn |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions